Other names for Siphoviridae

lh5 - siphoviridae
ll5 siphoviridae
ll5-siphoviridae
ll5 - siphoviridae
siphoviridae (ll5)
siphoviridae ll5

Synopsis of Siphoviridae

History

Siphoviridae is not an ingredient in nutritional products or herbal remedies. Rather, Siphoviridae is a family of bacteriophages—viruses that infect bacteria—widely studied in microbiology and biotechnology. Throughout history, bacteriophages, including members of the Siphoviridae family, have been explored for their medicinal potential, particularly in the field of phage therapy. In the early 20th century, before the widespread use of antibiotics, phage preparations were used as remedies to treat bacterial infections, especially in Eastern Europe and the former Soviet Union. These therapies often involved the use of phage mixtures to target pathogenic bacteria responsible for ailments such as dysentery, cholera, and wound infections.

With the advent of antibiotics, the use of phage therapy declined in the West. However, in recent decades, the rise of antibiotic-resistant bacteria has renewed interest in bacteriophage applications. Siphoviridae, with their highly specific host ranges and natural occurrence, are now once again being considered as potential therapeutic agents, especially for combating stubborn or resistant bacterial strains. Their ability to selectively target harmful bacteria, leaving beneficial microbiota untouched, is a unique advantage over traditional antibiotics.

Although Siphoviridae are not directly used in herbal combinations, research into combining phage therapy with herbal extracts is ongoing. Some studies suggest that integrating phages with plant-based antimicrobials could enhance the overall efficacy against infections. The positive contributions of Siphoviridae and other bacteriophages in modern medicine are thus promising, offering hope for new, effective, and natural therapeutic avenues amid growing antimicrobial resistance.

Traditional and scientific validation

Siphoviridae is a family of bacteriophages—viruses that specifically infect bacteria—being explored as an innovative ingredient in nutritional products, particularly for its potential to support gut microbiome balance. Historically, bacteriophages like those from the Siphoviridae family have played a vital role in food safety and preservation, especially in Eastern Europe and Russia, where phage therapy has been used for decades to manage bacterial infections. Their selectivity for bacteria, leaving human cells unharmed, has made them an attractive subject for modern research in functional foods and dietary supplements.

Recent scientific interest has focused on the capacity of Siphoviridae phages to target specific strains of undesirable bacteria in the digestive tract, potentially reducing harmful populations without disturbing beneficial microbes. Some in vitro studies and animal models have indicated that these phages may help maintain gut microbial balance, which is associated with overall digestive health and immune function. Emerging clinical studies are beginning to evaluate their safety and efficacy in human populations, though robust, large-scale trials remain limited.

While definitive health benefits in humans have yet to be fully established, early results are promising. Siphoviridae-based ingredients are generally recognized as safe, and their inclusion in nutritional products reflects a growing recognition of the microbiome’s role in health and well-being. More research is needed to validate their clinical benefits, but current evidence supports their potential as a natural, precise tool for modulating gut flora and contributing to gastrointestinal wellness.

Siphoviridae is used for these health conditions

Infection (Scientific)
Infection (bacterial) (Scientific)
Staph Infections (Scientific)

This ingredient is used to support these body systems

None

Products containing Siphoviridae

We currently have no products on Vitabase that contain this ingredient.